Overexpression of Bcl-2 protein in bronchoalveolar lavage lymphocytes and macrophages in sarcoidosis

Respiration

Volumn 73, Issue 2, 2006, Pages 221-226

  Mermigkis, C ^a   Polychronopoulos, V ^a   Mermigkis, D ^a   Tsakanika, K ^b   Heretis, M ^a   Karagianidis, N ^a   Bouros, D ^c  

^a Sismanoglio General District Hospital   (Greece)

^b SISMANOGLIO HOSPITAL   (Greece)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Antiapoptotic protein Bcl 2; Bronchoalveolar lavage; Pulmonary sarcoidosis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; PROTEIN BCL 2;

ADULT; APOPTOSIS; ARTICLE; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; FIBEROPTIC BRONCHOSCOPY; HUMAN; HUMAN CELL; IMMUNOPEROXIDASE STAINING; LUNG ALVEOLITIS; LUNG ALVEOLUS CELL; LUNG LAVAGE; LYMPHOCYTE; MACROPHAGE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOIDOSIS; THORAX RADIOGRAPHY;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOSCOPY; CASE-CONTROL STUDIES; FEMALE; FIBER OPTICS; HUMANS; LYMPHOCYTES; MACROPHAGES; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; SARCOIDOSIS;

EID: 33645242183     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088688     Document Type: Article

References (29)

1. Kerr JFR, Wyllie AH, Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-257.
2. Bosman FT, Visser BC, van Oeveren J: Apoptosis: pathophysiology of programmed cell death. Pathol Res Pract 1996;192:676-683.
3. Bingisser R, Stey C, Weller M, Frei K: Apoptosis in human alveolar macrophages is induced by endotoxin and is modulated by cytokines. Am J Respir Cell Mol Biol 1996;15:64-74.
4. Reed J: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
5. 2+ fluxes. Proc Natl Acad Sci USA 1994;91:6569-6573.
6. Yang E, Korsmeyer J: Molecular thanatopsis: a discourse on the Bcl-2 family in cell death. Blood 1996;88:386-401.
7. Solbach W, Moll H, Rollinghoff M: Lymphocytes play the music but the macrophage calls the tune. Immunol Today 1991;12:4-6.
8. Hunninghake GW, Costabel U, Ando M, et al: American Thoracic Society: statement on sarcoidosis. Am J Respir Crit Care Med 1999;160:736-755.
9. Costabel U: Sarcoidosis: clinical update. Eur Respir J Suppl 2001;32:565-568.
10. Dai H, Guzman J, Costabel U: Increased expression of apoptosis signaling receptors by alveolar macrophages in sarcoidosis. Eur Respir J 1999;13:1451-1454.
11. Agostini C, Zambello R, Sancetta R, Cerutti A, Milani A, Tassinari C, Facco M, Cipriani A, Semenzato G: Expression of tumor necrosis factor-receptor superfamily members by lung T lymphocytes in interstitial lung disease. Am J Respir Crit Care Med 1996;153:1359-1367.
12. Kunitake R, Kuwano K, Miyazaki H, Hagimoto N, Nomoto Y, Hara N: Apoptosis in the course of granulomatous inflammation in pulmonary sarcoidosis. Eur Respir J 1999;13:1329-1337.
13. Klech H, Pohl W: Technical recommendations and guidelines for bronchoalveolar lavage (BAL). Report of the European Society of Pneumology Task Group. Eur Respir J 1989;2:561-585.
14. Thompson A, Teschler H, Wang Y, Konietzko N, Costabel U: Preparation of bronchoalveolar lavage fluid with microscope slide smears. Eur Resp J 1996;9:603-608.
15. Giorno R: A comparison of two immunoperoxidase staining methods based on the avidin-biotin interaction. Diagn Immunol 1984;2:161-166.
16. Falini B, Taylor CR: New developments in immunoperoxidase techniques and their application. Arch Pathol Lab Med 1983;107:105-117.
17. Maynard JH: Rapid immunoperoxidase staining. J Histotech 1984;7:187-195.
18. Costabel U: Atlas of Bronchoalveolar Lavage. Philadelphia, Chapman and Hall, 1998, pp 67-69.
19. Quanjer PH, Tammeling GJ, Cotes JE: Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal Official Statement of the European Respiratory Society. Eur Respir J 1993;16(suppl):5-40.
20. White E: Life, death, and the pursuit of apoptosis. Genes Dev 1996;10:1-15.
21. King TE: Idiopathic pulmonary fibrosis; in Schwarz MI, King TE (eds): Interstitial Lung Disease, ed 3. Hamilton, Decker, 1998, pp 597-644.
22. Cree IA, Nurbhai S, Milne G, Beck JS: Cell death in granulomata: the role of apoptosis. J Clin Pathol 1987;40:1314-1319.
23. Shikuwa C, Kadota J, Mukae H, Iwashita T, Kaida H, Ishii H, Ishimatsu Y, Kohno S: High concentrations of soluble Fas ligand in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. Respiration 2002;69:242-246.
24. Stridh H, Plank A, Gigliotti D, Eklund A, Grunewald J: Apoptosis resistant bronchoalveolar lavage (BAL) fluid lymphocytes in sarcoidosis. Thorax 2002;57:897-901.
25. Rutherford RM, Kehren J, Staedtler F, Chibout SD, Egan JJ, Tamm M, Gilmartin JJ, Brutsche MH: Functional genomics in sarcoidosis-reduced or increased apoptosis? Swiss Med Wkly 2001;131:459-470.
26. Agostini C, Perin A, Semenzato G: Cell apoptosis and granulomatous lung diseases. Curr Opin Pulm Med 1998;4:261-266.
27. Mermigkis Ch, Tsakanika K, Polychronopoulos V, Karagianidis N, Mermigkis D, Bouros D: Expression of Bcl-2 protein in bronchoalveolar lavage populations from patients with idiopathic pulmonary fibrosis. Acta Cytologica 2001;45:914-918.
28. Tsiligianni I, Kyriakou D, Chrysofakis G, Siafakas NM, Bouros D: Comparison of sputum induction with bronchoalveolar lavage cell differential in patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:205-210.
29. Xaus J, Besalduch N, Comalada M, Marcoval J, Pujol R, Mana J, Celada A: High expression of p21 Waf1 in sarcoid granulomas: a putative role for long-lasting inflammation. J Leukoc Biol 2003;74:295-301.